Pfizer Inc.
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Abstract:

The present invention relates to new immunogenic compositions comprising conjughated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR.RTM., SYNFLORIX.RTM. and/or PREVNAR 13.RTM.. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.